Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dragos Nanul

Hospitalist Kenosha, WI Medical Doctor

NPI 1083660070 CMS profile 49289

10400 75Th St, Kenosha, WI 53142

Open in the dashboard

General payments

$1,685

41 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dragos Nanul of Kenosha, WI is reported in the CMS Open Payments database as having received $1,685 across 41 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Hospitalist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $171 2
2023 General $211 6
2022 General $866 22
2021 General $388 8
2020 General $28 2
2019 General $21 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dragos Nanul
  • Hospitalist median
  • Middle half of Hospitalist
  • National median

In program year 2025, general payments to Dragos Nanul were reported at $171. Among 6,882 Hospitalist profiles paid that year, the median was $86 and the middle half received between $30 and $191.

Show as a table
Year Dragos Nanul Hospitalist median Middle half National median
2019 $21 $96 $28–$201 $163
2020 $28 $48 $19–$125 $114
2021 $388 $70 $23–$167 $132
2022 $866 $85 $27–$174 $149
2023 $211 $89 $30–$191 $160
2024 $0 $95 $29–$204 $164
2025 $171 $86 $30–$191 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $472 13 payments
  2. Boston Scientific Corporation $245 2 payments
  3. AstraZeneca Pharmaceuticals LP $235 2 payments
  4. Pfizer Inc. $199 12 payments
  5. Novo Nordisk Inc $186 5 payments
  6. Stryker Corporation $144 2 payments
  7. Mylan Specialty L.P. $125 1 payment
  8. Edwards Lifesciences Corporation $26 1 payment
  9. UCB, Inc. $21 1 payment
  10. Merck Sharp & Dohme Corporation $17 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,685 41 payments
Products named General payments · program years 2019–2025
  1. XARELTO $472 13 payments
  2. ELIQUIS $199 12 payments
  3. RYBELSUS $170 4 payments
  4. WATCHMAN Access System $150 1 payment
  5. SPINEJACK $144 2 payments
  6. ANDEXXA $140 2 payments
  7. OPTABLATE $127 1 payment
  8. YUPELRI $125 1 payment
  9. BREZTRI $110 1 payment
  10. EKOSONIC $95 1 payment
  11. Other $241 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$45,888

Medicare's payments for the services billed

Medicare patients

324

Average age 76

Services billed

399

171 women, 153 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Chronic kidney disease 48%
Diabetes 45%
Heart failure 41%
Ischemic heart disease 40%
COPD 38%
Atrial fibrillation 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

41 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hospitalist in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record